Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	31.58	30.43	26.57	27.68
Short-Term Investments	187.55	73.14	70.18	-
Cash & Short-Term Investments	219.13	103.58	96.75	27.68
Cash Growth	111.56%	7.06%	249.58%	-
Accounts Receivable	17.12	12	4.45	-
Other Receivables	2.78	1.05	-	-
Receivables	19.89	13.05	4.45	-
Inventory	21.72	13.32	1.25	-
Prepaid Expenses	7.06	2.98	0.91	0.54
Restricted Cash	0.1	-	-	-
Other Current Assets	-	-	0.28	0.25
Total Current Assets	267.91	132.92	103.62	28.47
Property, Plant & Equipment	15.23	11.42	6.2	6.87
Long-Term Investments	45.43	-	-	-
Long-Term Deferred Charges	-	5.05	-	-
Other Long-Term Assets	0.18	0.25	0.22	0.19
Total Assets	328.74	149.65	110.04	35.53
Accounts Payable	5	2.85	1.17	0.43
Accrued Expenses	17.34	13.33	7.07	6.14
Current Portion of Leases	1.94	1.53	1.22	0.98
Current Unearned Revenue	1.56	0.94	0.09	-
Other Current Liabilities	5.1	2.5	1.05	1.32
Total Current Liabilities	30.92	21.15	10.61	8.87
Long-Term Leases	5.37	5.73	3	3.16
Long-Term Unearned Revenue	3.3	1.86	0.26	-
Other Long-Term Liabilities	1.55	44.9	37.57	10.5
Total Liabilities	41.13	73.63	51.43	22.53
Common Stock	0	0	0	0
Additional Paid-In Capital	657.14	51.31	26.42	15.53
Retained Earnings	-369.94	-296.74	-229.66	-185.57
Comprehensive Income & Other	0.4	0.07	0.14	-
Total Common Equity	287.61	-245.36	-203.11	-170.03
Shareholders' Equity	287.61	76.01	58.61	13
Total Liabilities & Equity	328.74	149.65	110.04	35.53
Total Debt	7.3	7.26	4.22	4.13
Net Cash (Debt)	211.82	96.32	92.52	23.54
Net Cash Growth	119.91%	4.11%	293.01%	-
Net Cash Per Share	5.23	15.13	17.44	4.71
Filing Date Shares Outstanding	44.38	43.35	5.03	5
Total Common Shares Outstanding	44.36	6.67	5.03	5
Working Capital	236.98	111.78	93.02	19.59
Book Value Per Share	6.48	-36.80	-40.39	-34.02
Tangible Book Value	287.61	-245.36	-203.11	-170.03
Tangible Book Value Per Share	6.48	-36.80	-40.39	-34.02
Machinery	10.19	7.48	5.78	5.56
Construction In Progress	3.34	1.74	0.17	0.18
Leasehold Improvements	0.83	0.81	0.95	0.95

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q